Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Peter Hoskin
Affiliation
Mount Vernon Cancer Centre
ORCID
Career Start Year
1985
Papers
528
H Index
77
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37923687
Image-guided Interstitial Brachytherapy in the Treatment of Primary and Recurrent Vulvovaginal Gynaecological Malignancies.
Clin Oncol (R Coll Radiol)
2024
36347734
Nature versus Nurture: what Underpins Great Leadership?
Clin Oncol (R Coll Radiol)
2023
37488951
CBCT-based deformable dose accumulation of external beam radiotherapy in cervical cancer.
Acta Oncol
2023
37662704
Defining Oligometastatic Bladder Cancer: A Systematic Review.
Eur Urol Open Sci
2023
37796729
MRI-guided Pelvic Radiation Therapy: A Primer for Radiologists.
Radiographics
2023
37478391
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer.
J Clin Oncol
2023
37835443
Stages I-III Inoperable Endometrial Carcinoma: A Retrospective Analysis by the Gynaecological Cancer GEC-ESTRO Working Group of Patients Treated with External Beam Irradiation and 3D-Image Guided Brachytherapy.
Cancers (Basel)
2023
37059334
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Radiother Oncol
2023
37217391
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
Eur Urol
2023
37315584
Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literature.
Radiother Oncol
2023
37150445
Are hybrid conferences the new standard?
Radiother Oncol
2023
37081704
Appropriateness of the 30-day expected mortality metric in palliative radiation treatment: a narrative review.
Ann Palliat Med
2023
37246040
Functional Magnetic Resonance Imaging in Cervical Cancer Diagnosis and Treatment.
Clin Oncol (R Coll Radiol)
2023
37179143
Salvage Reirradiation Options for Treating Local Recurrence After Previous Prostatectomy and Radiotherapy: Where Do We Stand?
Eur Urol Oncol
2023
37240301
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.
Int J Mol Sci
2023
37303218
A critical appraisal of the four systematic reviews and meta-analysis on stereotactic body radiation therapy versus external beam radiotherapy for painful bone metastases and where we go from here.
Ann Palliat Med
2023
37198374
Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings.
Radiol Med
2023
37397380
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost.
Front Oncol
2023
37330057
Impact of prostate radiotherapy on survival outcomes in clinically node-positive prostate cancer: A multicentre retrospective analysis.
Radiother Oncol
2023
36720348
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors.
Radiother Oncol
2023
36588012
A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years.
Clin Oncol (R Coll Radiol)
2023
36549006
Feasibility of using a dual isocentre technique for treating cervical cancer on the 1.5 T MR-Linac.
Phys Med Biol
2023
36517190
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer.
Semin Radiat Oncol
2023
36870608
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.
Radiother Oncol
2023
36641039
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Int J Radiat Oncol Biol Phys
2023
36736920
Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation.
Int J Radiat Oncol Biol Phys
2023
36764876
Improving Quality of Life with Brachytherapy for Urological Malignancies.
Clin Oncol (R Coll Radiol)
2023
36566990
The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice.
Radiother Oncol
2023
36599120
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
J Clin Oncol
2023
32139358
Bayesian methods in palliative care research: cancer-induced bone pain.
BMJ Support Palliat Care
2022
35618101
Prognostic factors for survival and ambulatory status at 8Â weeks with metastatic spinal cord compression in the SCORAD randomised trial.
Radiother Oncol
2022
35616660
The impact of an educational tool in cervix image registration across three imaging modalities.
Br J Radiol
2022
35411939
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
2022
35730624
Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature.
Mol Med Rep
2022
35661676
ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases.
Radiother Oncol
2022
35688398
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases.
Radiother Oncol
2022
35850265
Update on the systematic review/meta-analysis of uncomplicated bone metastases treated with external beam radiation.
Radiother Oncol
2022
35512723
NICE 2020 guideline for the management of colorectal cancer.
Lancet Oncol
2022
36612036
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
Cancers (Basel)
2022
36439503
Imaging hypoxia in endometrial cancer: How and why should it be done?
Front Oncol
2022
36174633
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.
Lancet Oncol
2022
35964765
Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors.
Radiother Oncol
2022
36100905
Stereotactic body radiotherapy versus conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis of randomised controlled trials.
Radiat Oncol
2022
36199996
Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy - interventional radiotherapy.
J Contemp Brachytherapy
2022
36328092
Brachytherapy training survey among radiation oncology residents in Europe.
Radiother Oncol
2022
36351720
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT).
BMJ Open
2022
35044080
Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
Pediatr Blood Cancer
2022
34918547
The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning.
Br J Radiol
2022
35314092
Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel.
Clin Oncol (R Coll Radiol)
2022
35282933
Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy.
Clin Oncol (R Coll Radiol)
2022
1 - 50 of 528
Column Actions
Search
Recommended Authors
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
19
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year
2010
Number of shared co-authors
21
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year
2008
Number of shared co-authors
13
Bradley J Stish
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
24
Bridget F Koontz
Duke University School of Medicine
Career Start Year
2006
Number of shared co-authors
20
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
2006
Number of shared co-authors
18
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Career Start Year
2005
Number of shared co-authors
4
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year
2005
Number of shared co-authors
15
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year
2004
Number of shared co-authors
18
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
7
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
5
Chandana A Reddy
Cleveland Clinic
Career Start Year
2000
Number of shared co-authors
16
Constantine A Mantz
University of Chicago
Career Start Year
1997
Number of shared co-authors
17
Michael L Steinberg
University of California los angeles
Career Start Year
1996
Number of shared co-authors
31
Laurence Collette
Belgium International Drug Development Institute
Career Start Year
1995
Number of shared co-authors
19
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
8
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year
1994
Number of shared co-authors
18
William Robert Lee
Duke University School of Medicine
Career Start Year
1993
Number of shared co-authors
24
Rafael Mart??nez-Monge
Clinica Universitaria de Navarra
Career Start Year
1993
Number of shared co-authors
13
Patrick A Kupelian
university of california los angeles Medical Center
Career Start Year
1993
Number of shared co-authors
26
Thomas M Pisansky
Mayo Clinic
Career Start Year
1992
Number of shared co-authors
35
Philippe Lambin
Maastricht University
Career Start Year
1992
Number of shared co-authors
16
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year
1991
Number of shared co-authors
26
Charles R Thomas
Oregon Health & Science University
Career Start Year
1990
Number of shared co-authors
10
David Joseph
Sir Charles Gairdner Hospital
Career Start Year
1990
Number of shared co-authors
19
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1990
Number of shared co-authors
13
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Career Start Year
1988
Number of shared co-authors
21
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year
1987
Number of shared co-authors
29
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
9
James W Denham
University of Newcastle
Career Start Year
1980
Number of shared co-authors
17
row(s) 1 - 30 of 30
Collaborators
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers
51
Edward Chow
University of Toronto
Co-authored papers
31
Catharine M L West
University of Manchester
Co-authored papers
24
Lukas J A Stalpers
Co-authored papers
19
William F Hartsell
Proton Therapy Center- Northwestern University
Co-authored papers
11
Michael Brundage
Cancer Centre of Southeastern Ontario
Co-authored papers
8
Oliver Sartor
Tulane University School of Medicine
Co-authored papers
7
William F Demas
Salem Regional Medical Center
Co-authored papers
6
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers
5
Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Co-authored papers
5
Douglas F Easton
University of Cambridge
Co-authored papers
5
Lingjian Yang
Ankang University
Co-authored papers
5
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers
5
Keyue Ding
Queen's University
Co-authored papers
4
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers
4
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers
4
Adrian L Harris
University of Oxford
Co-authored papers
4
Henry Mandeville
Co-authored papers
4
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Co-authored papers
4
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers
3
Francesca M Buffa
University of Oxford
Co-authored papers
3
Neeraj Agarwal
Co-authored papers
3
James N'Dow
University of Aberdeen
Co-authored papers
3
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers
3
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Co-authored papers
3
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Co-authored papers
3
Hendrik Van Poppel
University Hospitals Leuven
Co-authored papers
3
Robert G Bristow
University of Toronto
Co-authored papers
3
Mark Frydenberg
Monash University
Co-authored papers
3
1 - 30